Canada markets closed

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.32+0.16 (+0.69%)
At close: 04:00PM EDT
23.32 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.10B
Enterprise Value 2.14B
Trailing P/E N/A
Forward P/E 769.23
PEG Ratio (5 yr expected) 1.40
Price/Sales (ttm)2.54
Price/Book (mrq)2.76
Enterprise Value/Revenue 2.76
Enterprise Value/EBITDA -25.45

Trading Information

Stock Price History

Beta (5Y Monthly) 1.97
52-Week Change 34.04%
S&P500 52-Week Change 326.14%
52 Week High 325.95
52 Week Low 313.82
50-Day Moving Average 321.27
200-Day Moving Average 319.31

Share Statistics

Avg Vol (3 month) 3742.42k
Avg Vol (10 day) 3823.7k
Shares Outstanding 590.51M
Implied Shares Outstanding 690.51M
Float 871.41M
% Held by Insiders 12.09%
% Held by Institutions 1106.20%
Shares Short (May 15, 2024) 45.1M
Short Ratio (May 15, 2024) 45.73
Short % of Float (May 15, 2024) 47.90%
Short % of Shares Outstanding (May 15, 2024) 45.63%
Shares Short (prior month Apr 15, 2024) 45.5M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Mar 26, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -30.30%
Operating Margin (ttm)-13.80%

Management Effectiveness

Return on Assets (ttm)-6.60%
Return on Equity (ttm)-29.41%

Income Statement

Revenue (ttm)774.2M
Revenue Per Share (ttm)9.11
Quarterly Revenue Growth (yoy)11.60%
Gross Profit (ttm)N/A
EBITDA -67.8M
Net Income Avi to Common (ttm)-234.6M
Diluted EPS (ttm)-2.80
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)104.3M
Total Cash Per Share (mrq)1.15
Total Debt (mrq)146.8M
Total Debt/Equity (mrq)19.32%
Current Ratio (mrq)1.99
Book Value Per Share (mrq)8.40

Cash Flow Statement

Operating Cash Flow (ttm)-96.3M
Levered Free Cash Flow (ttm)-36.7M